Recent Approaches Encompassing the Phenotypic Cell Heterogeneity for Anticancer Drug Efficacy Evaluation
Open Access
- 8 April 2020
- book chapter
- Published by IntechOpen
Abstract
Despite the advancements in biomarker-based personalized cancer therapy, the inadequacy of molecular and genetic profiling in identifying effective drug combinations was defined in most cases. Drug resistance remains a major limitation of the current predictive oncology. Emerging reports indicate that the success of anticancer therapy is usually limited by intratumoral heterogeneity which is not captured by the existing cancer cell biomarker-based approaches. Cell heterogeneity, not only genetic but also phenotypic, is considered to be the root cause of resistance to anticancer treatment, cancer progression, and the presence of cancer stem cells. Therefore, functional testing of live cells representing various cell types within the tumor exposed to potential therapies is needed for identification of effective drug combinations. Here we look at the different existing model systems, including ex vivo models of the patient’s tumor cells, 2D/3D in vitro cultures/cocultures, patient-derived cellular organoids, single-cell models, ex vivo tumor platforms containing tumor microenvironment and extracellular matrix, etc., scoping at drug efficacy evaluation and solving the problem of cancer resistance.Keywords
This publication has 195 references indexed in Scilit:
- Development of an in Vitro 3D Tumor Model to Study Therapeutic Efficiency of an Anticancer DrugMolecular Pharmaceutics, 2013
- Cancer heterogeneity: implications for targeted therapeuticsBritish Journal of Cancer, 2013
- A restricted cell population propagates glioblastoma growth after chemotherapyNature, 2012
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityNature, 2012
- Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomesNature Medicine, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Models for prevention and treatment of cancer: Problems vs promisesBiochemical Pharmacology, 2009
- Integrins mediate adhesion of medulloblastoma cells to tenascin and activate pathways associated with survival and proliferationLaboratory Investigation, 2008
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008
- Extensive multi‐organ metastasis following orthotopic onplantation of histologically‐intact human bladder carcinoma tissue in nude miceInternational Journal of Cancer, 1991